C B McAllister

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

Kōichi Nakamura, Fumio Goto, Wayne A. Ray et al. · Clinical Pharmacology & Therapeutics · 1985 · 456 citations

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

Lyle A. Siddoway, Katherine A. Thompson, C B McAllister et al. · Circulation · 1987 · 271 citations

Human Polymorphism, Pharmacotherapy, Propafenone Metabolism +17

Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism

P J Wedlund, W S Aslanian, C B McAllister et al. · Clinical Pharmacology & Therapeutics · 1984 · 264 citations

Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.

P J Wedlund, W S Aslanian, E Jacqz et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 96 citations

Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.

Raghvendra K. Dubey, C B McAllister, M. Inoue et al. · Journal of Clinical Investigation · 1989 · 93 citations · Full text